Wekerle T, Muckenhuber M, Heinzel A, Weijler AM, David AF, Kainz V, Hu K, Mucha J, Mengrelis K, Reindl-Schwaighofer R, Böhmig GA, Watschinger B, Györi G, Soliman T, Salat A, Schwarz C, Muhm M, Heinze G, Wolzt M, Worel N, Fortschegger M, Lion T, Regele H, Berlakovich G, Halloran PF, Edinger M, Oberbauer R.
// Publications
206. Donor bone marrow together with recipient regulatory T cells induces chimerism without irradiation in kidney transplantation. Sci Transl Med. 2026 (in press) (IF 15.6)
205. Design, rationale, and baseline characteristics of the dapagliflozin in haemodialysis (DAPA-HD) trial. ESC Heart Fail 2026, 13(3):xvag104. (IF 3.7)
Zelniker TA, Paschen C, Mann C, Eigner M, Hafner-Gießauf H, Kletzmayr J, Lorenz M, Ludvik B, Stulnig T, Waller I, Werzowa J, Hödlmoser S, Hengstenberg C, Oberbauer R, Hecking M.
204. Donor-reactive clonotypes are overrepresented in the urinary T-cell repertoire during kidney transplant rejection and show distinct dynamics in the circulation. Am J Transplant 2026 (in press) (IF 8.9)
Aschauer C, Heinzel A, Hu K, Chen HS, Reindl-Schwaighofer R, Wekerle T, Sykes M, David AF, Oberbauer R.
202. DARC and Anti-Duffy Antibodies in the Line of Fire: The Challenges in Pinpointing the Etiology of Microcirculation Inflammation to a Distinct Entity. Transpl Int. 2026;38:15601. (IF 2.7)
Eskandary F, Körmöczi GF, Schönbacher M, Fischer G, Faé I, Wenda S, Koren D, Oberbauer R, Reindl-Schwaighofer R, Heinzel A, Kläger J, Kozakowski N, Segerer S, Doberer K, Hidalgo LG, Schachner H, Böhmig GA, Regele H.